8-K
Current Report
Denali Therapeutics Inc. Filed Acc 0001714899-26-000036
New debt or obligation · Regulation FD disclosure
- Item 2.03 Creation of a direct financial obligation
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading dnli-20260327.htm…